Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Old Second Bancorp
OSBC
$1.31B
| $5.94M | ﹤0.01% |
357,036
-9,444
| -3% | -$169K |
|
2202
Conduent
CNDT
$271M
| $5.94M | ﹤0.01% |
2,199,536
+235,179
| +12% | +$860K |
|
2203
CEVA Inc
CEVA
$992M
| $5.93M | ﹤0.01% |
231,369
+4,624
| +2% | +$149K |
|
2204
Clearwater Paper
CLW
$369M
| $5.92M | ﹤0.01% |
233,474
+41,633
| +22% | +$1.16M |
|
|
CGAU
2205
Centerra Gold
CGAU
$3.87B
| $5.79M | ﹤0.01% |
912,931
-72,382
| -7% | -$442K |
|
2206
Qfin Holdings
QFIN
$1.59B
| $5.79M | ﹤0.01% |
128,920
| – | – |
|
2207
Hovnanian Enterprises
HOV
$789M
| $5.77M | ﹤0.01% |
55,067
+9,445
| +21% | +$1.14M |
|
2208
Titan International
TWI
$465M
| $5.75M | ﹤0.01% |
685,446
+191,035
| +39% | +$1.58M |
|
2209
National Grid
NGG
$80.8B
| $5.75M | ﹤0.01% |
91,463
+23,590
| +35% | +$1.39M |
|
2210
Anavex Life Sciences
AVXL
$304M
| $5.75M | ﹤0.01% |
669,911
-7,304
| -1% | -$69K |
|
2211
Byline Bancorp
BY
$1.79B
| $5.75M | ﹤0.01% |
219,677
-3,953
| -2% | -$111K |
|
|
SMLR
2212
DELISTED
Semler Scientific
SMLR
| $5.74M | ﹤0.01% |
158,576
+109,951
| +226% | +$5.15M |
|
2213
American Express Global Business Travel
GBTG
$4.93B
| $5.73M | ﹤0.01% |
789,708
-22,534
| -3% | -$190K |
|
2214
Baytex Energy
BTE
$2.89B
| $5.72M | ﹤0.01% |
2,582,580
+274,269
| +12% | +$653K |
|
2215
E.W. Scripps
SSP
$270M
| $5.7M | ﹤0.01% |
1,926,461
+1,171,102
| +155% | +$2.56M |
|
2216
Vermilion Energy
VET
$1.68B
| $5.68M | ﹤0.01% |
701,870
+40,586
| +6% | +$363K |
|
2217
10x Genomics
TXG
$5.79B
| $5.66M | ﹤0.01% |
648,410
+108,744
| +20% | +$1.37M |
|
|
UDMY
2218
DELISTED
Udemy
UDMY
| $5.64M | ﹤0.01% |
727,128
-15,762
| -2% | -$134K |
|
2219
NB Bancorp
NBBK
$997M
| $5.63M | ﹤0.01% |
311,436
-8,000
| -3% | -$149K |
|
2220
American Superconductor
AMSC
$1.59B
| $5.62M | ﹤0.01% |
309,681
-8,188
| -3% | -$204K |
|
2221
Transcat
TRNS
$885M
| $5.61M | ﹤0.01% |
75,296
-404
| -0.5% | -$33.9K |
|
2222
Arcus Biosciences
RCUS
$3.61B
| $5.6M | ﹤0.01% |
714,002
+134,379
| +23% | +$1.56M |
|
2223
ING
ING
$102B
| $5.6M | ﹤0.01% |
285,853
+51,324
| +22% | +$912K |
|
2224
Mercantile Bank Corp
MBWM
$1.06B
| $5.6M | ﹤0.01% |
128,885
-61,077
| -32% | -$2.83M |
|
2225
Camden National
CAC
$992M
| $5.55M | ﹤0.01% |
137,209
+18,493
| +16% | +$798K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.